viral
proteas
proven
select
use
remov
fusion
tag
fusion
protein
express
system
key
enzym
viral
lifecycl
main
proteas
pro
attract
drug
design
target
sar
coronaviru
sarscov
etiolog
agent
respons
outbreak
sever
acut
respiratori
syndrom
sar
studi
sarscov
pro
use
specif
remov
gst
tag
new
fusion
protein
express
system
report
new
method
produc
wildtyp
wt
sarscov
pro
authent
n
c
termini
compar
activ
wt
proteas
three
differ
type
sarscov
pro
addit
residu
n
c
terminu
result
show
addit
residu
n
terminu
c
terminu
pro
detriment
enzym
activ
explain
crystal
structur
wt
sarscov
pro
complex
michael
acceptor
inhibitor
determin
resolut
respect
crystal
structur
reveal
first
residu
proteas
import
sustain
substratebind
pocket
inhibitor
bind
studi
suggest
sarscov
pro
could
serv
new
tagcleavag
endopeptidas
protein
overproduct
wt
sarscov
pro
appropri
mechanist
character
inhibitor
design
age
proteom
product
pure
protein
highthroughput
manner
requir
structur
function
studi
especi
protein
structur
studi
one
main
bottleneck
produc
adequ
quantiti
solubl
properli
fold
recombin
protein
fusion
protein
express
system
wide
use
purpos
basic
research
industri
fusion
domain
small
tag
express
partner
passeng
protein
gener
remov
purif
might
interfer
function
biochem
biophys
characterist
protein
henc
endopeptidas
bovin
thrombin
bovin
factor
xa
human
rhinoviru
proteas
tobacco
etch
viru
tev
proteas
routin
use
remov
fusion
domain
viral
proteas
eg
human
rhinoviru
proteas
tev
proteas
proven
select
use
date
therefor
develop
novel
viral
xx
hy
made
equal
contribut
work
abbrevi
use
sar
sever
acut
respiratori
syndrom
sarscov
sar
coronaviru
pro
main
proteas
gst
glutathionestransferas
wt
wildtyp
enzym
authent
n
c
termini
gswt
wildtyp
enzym
two
addit
amino
acid
residu
gs
n
terminu
gplgswt
wildtyp
enzym
five
addit
amino
acid
residu
gplg
n
terminu
wtgph
wildtyp
enzym
eight
addit
amino
acid
residu
gphhhhhh
c
terminu
email
address
correspond
author
raozh
xtaltsinghuaeducn
proteas
high
specif
activ
help
proteom
research
sar
coronaviru
sarscov
etiolog
agent
respons
global
outbreak
lifethreaten
diseas
caus
approxim
death
worldwid
coronaviru
main
proteas
pro
play
key
role
mediat
viral
replic
transcript
identifi
attract
target
antisar
drug
design
group
publish
first
crystal
structur
sarscov
pro
thereaft
sever
group
publish
structur
pro
complex
azapeptid
epoxid
inhibitor
pro
form
homodim
crystal
solut
protom
consist
three
domain
domain
ii
resembl
chymotrypsin
wherea
domain
iii
globular
cluster
five
mostli
antiparallel
sarscov
pro
catalyt
dyad
consist
substratebind
pocket
locat
cleft
domain
ii
ntermin
residu
domain
nfinger
pro
consid
import
role
proteolyt
activ
although
import
dimer
report
inconsist
result
particular
mutat
involv
form
ion
pair
result
fourfold
decreas
activ
delet
ntermin
residu
result
almost
complet
inact
sarscov
pro
sarscov
pro
character
suffici
two
particular
aspect
drew
attent
first
highli
select
substrat
sequenc
second
display
high
level
proteolyt
activ
although
inconsist
kinet
paramet
report
sarscov
pro
k
cat
k
rang
properti
indic
sarscov
pro
promis
candid
endopeptidas
remov
fusion
tag
studi
sarscov
pro
util
remov
fusion
domain
overproduct
calbindin
member
calmodulin
superfamili
novel
glutathionestransferas
gst
fusion
protein
express
system
obtain
peptidas
high
catalyt
effici
develop
new
method
produc
wildtyp
wt
sarscov
pro
authent
n
c
termini
investig
activ
differ
among
sever
sarscov
pro
construct
crystal
structur
wt
pro
complex
inhibitor
solv
explain
mechan
enhanc
activ
order
take
advantag
sarscov
pro
endopeptidas
new
gst
fusion
protein
express
vector
design
pgstm
construct
anoth
fusion
vector
ge
healthcar
result
plasmid
retain
whole
multipl
clone
site
howev
linker
gst
gene
gene
interest
replac
nucleotid
encod
uniqu
ntermin
autocleavag
site
sarscov
pro
consist
amino
acid
residu
see
figur
sequenc
confirm
cleavag
site
tsavlqsgfrk
insert
correctli
express
purif
calbindin
use
pgstm
express
system
calbindin
member
calmodulin
superfamili
propos
function
import
intracellular
ca
buffer
protein
took
protein
interest
structur
studi
protein
clone
express
purifi
use
new
protein
express
system
onestep
purif
calbindin
protein
five
addit
residu
sgfrk
n
terminu
authent
c
terminu
analyz
sdspage
puriti
shown
figur
b
around
mg
calbindin
obtain
l
bacteri
cultur
crystallograph
analysi
calbindin
underway
earlier
studi
wildtyp
sarscov
pro
two
addit
residu
gs
n
terminu
gswt
use
determin
kinet
paramet
avoid
potenti
effect
extran
ntermin
residu
enzym
activ
develop
new
method
produc
wt
sarscov
pro
first
four
amino
acid
avlq
correspond
site
ntermin
autocleavag
sequenc
sarscov
pro
introduc
gst
tag
first
residu
proteas
thu
authent
n
terminu
would
becom
avail
autocleavag
protein
express
second
eight
amino
acid
gphhhhhh
abbrevi
gph
gp
correspond
site
rhinoviru
proteas
see
tabl
ad
last
glutamin
residu
c
terminu
figur
c
strategi
intend
yield
authent
c
terminu
follow
cleavag
rhinoviru
proteas
despit
appear
unreason
sinc
sarscov
rhinoviru
belong
differ
famili
coronavirida
picornavirida
respect
strategi
use
follow
reason
extra
domain
iii
sarscov
pro
differ
rhinoviru
proteas
mani
aspect
howev
share
sever
similar
cleavag
sequenc
substraterecognit
pocket
nativecomplex
structur
two
proteas
publish
date
subsit
critic
substrat
bind
two
proteas
thu
correspond
site
taken
consider
design
recognit
sequenc
tabl
list
ctermin
autocleavag
site
sarscov
pro
substrat
sequenc
human
rhinoviru
proteas
show
five
site
ident
two
proteas
except
substanti
differ
embodi
two
substrat
sequenc
limit
henc
reason
rhinoviru
proteas
could
recogn
octapeptid
substrat
whose
site
deriv
ctermin
autoprocess
site
sarscov
pro
howev
replac
lysin
prolin
site
would
arrest
autocleavag
group
recent
solv
crystal
structur
mutant
sarscov
pro
complex
amino
acid
residu
peptidyl
substrat
unpublish
result
complex
structur
reveal
substitut
pro
would
result
steric
hindranc
pro
main
chain
sarscov
hinder
substrat
bind
basi
analysi
hypothes
rhinoviru
proteas
sarscov
pro
could
recogn
octapeptid
substrat
sdspage
analysi
see
figur
show
niaffin
chromatographi
sarscov
pro
wtgph
form
impli
ntermin
gst
tag
remov
effici
autocleavag
protein
express
escherichia
coli
differ
lane
lane
indic
gph
tag
inde
remov
rhinoviru
proteas
cleavag
confirm
modifi
substrat
sarscov
pro
could
recogn
rhinoviru
proteas
matrixassist
laser
desorptionion
timeofflight
mass
spectrometri
malditof
ms
analysi
indic
wtgph
wt
pro
accord
predict
molecular
mass
see
tabl
ascertain
whether
addit
residu
would
interfer
catalyt
activ
sarscov
pro
determin
kinet
paramet
gplgswt
five
addit
residu
gplg
n
terminu
wt
gswt
wtgph
wt
sarscov
pro
see
tabl
catalyt
effici
enzym
best
defin
k
cat
k
tabl
show
wt
proteas
highest
cleavag
effici
k
cat
k
gplgswt
lowest
k
cat
k
activ
wt
proteas
authent
n
c
termini
greater
gplgswt
greater
gswt
furthermor
result
suggest
increas
number
addit
residu
n
terminu
would
result
greater
decreas
activ
howev
activ
wtgph
onethird
wt
enzym
suggest
addit
residu
c
terminu
less
effect
activ
order
shed
light
differ
activ
determin
crystal
structur
wt
sarscov
pro
resolut
publish
crystal
structur
sarscov
pro
gplgswt
form
crystal
belong
space
group
asymmetr
unit
contain
dimer
two
protom
design
b
within
dimer
protom
activ
form
protom
b
show
inact
form
result
partial
collaps
subsit
contrast
crystal
wt
sarscov
pro
belong
space
group
asymmetr
unit
contain
one
protom
typic
dimer
two
protom
design
b
two
protom
dimer
relat
crystallograph
symmetri
axi
catalyt
compet
conform
residu
protom
residu
identifi
electron
densiti
map
apart
differ
subsit
sarscov
pro
protom
seen
new
structur
similar
member
dimer
origin
structur
see
figur
compar
latter
structur
protom
new
crystal
form
display
overal
rmsd
c
atom
protom
protom
b
follow
discuss
consid
differ
substratebind
site
two
structur
detail
site
sarscov
pro
absolut
specif
gln
site
consist
sidechain
mainchain
atom
site
protom
origin
structur
gplgswt
nh
group
unabl
donat
hydrogen
bond
simultan
carboxyl
group
mainchain
carbonyl
group
due
presenc
addit
residu
n
terminu
although
distanc
suitabl
hydrogen
bond
format
howev
newli
solv
wt
structur
amino
group
nh
serb
one
protom
donat
hydrogen
bond
carboxyl
group
glua
figur
hydrogen
bond
mainchain
carbonyl
group
phea
thu
stabil
pocket
induc
seri
conform
chang
instanc
nh
glya
particip
directli
format
oxyanion
hole
move
toward
activ
site
main
chain
residu
move
toward
subsit
sidechain
asna
flip
shift
stabil
serb
protom
display
catalyt
compet
conform
subsit
protom
origin
structur
origin
structur
pocket
protom
b
partli
collaps
compar
wt
protom
electron
densiti
visibl
residu
reorient
interact
possibl
proton
undergo
dramat
conform
chang
phenyl
ring
move
much
move
toward
activ
site
figur
superposit
pocket
gplgswt
wt
sarscov
pro
stereo
superposit
pocket
protom
gplgswt
protom
wt
sarscov
pro
protom
wt
blue
protom
gplgswt
yellow
protom
b
wt
magenta
protom
b
gplgswt
red
wt
structur
amino
group
nh
protom
b
donat
hydrogen
bond
carboxyl
group
hydrogen
bond
mainchain
carbonyl
group
protom
stabil
pocket
nh
move
toward
activ
site
main
chain
residu
move
toward
subsit
sidechain
asna
flip
shift
compar
protom
gplgswt
b
superposit
pocket
protom
b
gplgswt
protom
wt
sarscov
pro
protom
wt
blue
protom
b
gplgswt
yellow
protom
b
wt
magenta
protom
gplgswt
red
pocket
protom
b
collaps
partli
reorient
residu
electron
densiti
visibl
residu
leav
space
accommod
tetrahedr
reaction
intermedi
figur
b
structur
variat
account
higher
activ
wt
proteas
compar
gplgswt
gswt
proteas
observ
also
gplgswt
proteas
lower
activ
gswt
proteas
might
result
addit
flexibl
residu
n
terminu
locat
close
activ
site
would
hinder
substrat
bind
contrast
n
terminu
c
terminu
wt
protom
residu
locat
far
substratebind
pocket
partner
protom
therefor
addit
residu
gph
c
terminu
expect
less
effect
enzym
activ
see
tabl
previou
studi
design
irrevers
anticoronaviru
inhibitor
design
figur
consist
ester
one
type
michael
acceptor
incorpor
peptidyl
portion
evalu
seri
timedepend
inhibitor
requir
pseudo
secondord
rate
constant
k
k
k
k
repres
equilibrium
bind
constant
inactiv
rate
constant
coval
bond
format
respect
assay
inhibit
differ
type
pro
determin
whether
addit
residu
would
affect
inhibitor
bind
preliminari
inhibit
assay
observ
could
complet
inactiv
wt
wtgph
proteas
preincub
proteas
fivefold
molar
excess
enzym
min
gplgswt
gswt
proteas
see
supplementari
data
figur
strict
kinet
paramet
list
tabl
show
secondord
rate
constant
wt
proteas
k
k
approxim
equal
wtgph
k
k
howev
secondord
rate
constant
complex
structur
nh
group
protom
b
still
hydrogenbond
carboxyl
group
carbonyl
group
protom
stabil
pocket
complex
structur
howev
two
hydrogen
bond
describ
found
instead
order
water
molecul
observ
pocket
protom
wt
blue
protom
gplgswt
yellow
inhibitor
complex
wt
magenta
inhibitor
complex
gplgswt
red
protom
b
wt
green
protom
b
gplgswt
cyan
k
k
gswt
decreas
greater
differ
impli
first
residu
sarscov
pro
also
play
import
role
inhibitor
bind
determin
crystal
structur
wt
sarscov
pro
complex
inhibitor
resolut
substanti
differ
structur
wt
complex
gplgswt
complex
report
previous
still
lie
subsit
gplgswt
complex
structur
bind
protom
b
sarscov
pro
ident
normal
manner
thu
discuss
protom
protom
gplgswt
pro
complex
nh
group
carboxyl
group
mainchain
carbonyl
group
beyond
distanc
format
hydrogen
bond
howev
order
water
molecul
situat
bottom
subsit
connect
proteas
water
donat
two
hydrogen
bond
carboxyl
group
mainchain
carbonyl
group
accept
two
hydrogen
bond
lactam
sidechain
although
water
molecul
help
stabil
inhibitor
bind
pocket
occupi
part
space
subsit
due
steric
hindranc
lactam
abl
insert
subsit
protom
wt
pro
complex
water
molecul
found
bottom
pocket
consequ
carboxyl
group
glua
move
upward
form
hydrogen
bond
nh
lactam
compet
conform
subsit
still
maintain
via
interact
nh
serb
carboxyl
group
glua
figur
b
mainchain
carbonyl
group
phea
structur
data
demonstr
first
residu
import
also
inhibitor
bind
account
potent
inhibit
wt
gplgswt
gswt
proteas
although
sarscov
notori
caus
lethal
diseas
human
posit
element
may
result
lifethreaten
viru
studi
sarscov
pro
engin
serv
novel
endopeptidas
remov
fusion
tag
recombin
protein
overproduct
tabl
show
advantag
sarscov
pro
compar
routin
use
proteas
method
product
substrat
specif
cleavag
effici
human
thrombin
bovin
factor
xa
extract
plasma
requir
complic
procedur
although
possess
high
level
cleavag
effici
addit
select
substrat
viral
proteas
wt
sarscov
pro
suitabl
overexpress
e
coli
highli
specif
substrat
furthermor
superior
activ
k
cat
k
rhinoviru
tev
proteas
therefor
sarscov
pro
suitabl
candid
sitespecif
cleavag
fusion
protein
express
system
cleavag
effici
wtgph
still
high
despit
addit
residu
c
terminu
highli
purifi
pro
form
could
obtain
simpl
onestep
purif
shown
overload
sdspage
gel
figur
sake
addit
six
histidin
residu
c
terminu
readili
separ
protein
interest
affin
chromatographi
remov
fusion
tag
advantag
suggest
form
sarscov
pro
could
import
industri
applic
one
disadvantag
recombin
protein
express
commonli
produc
addit
amino
acid
residu
termini
wild
type
protein
sarscov
pro
studi
sever
research
group
report
inconsist
result
kinet
paramet
proteas
k
cat
k
rang
slight
differ
method
hplc
fretbas
method
substrat
use
would
account
entir
phenomenon
first
publish
crystal
structur
sarscov
pro
addit
residu
n
terminu
group
provid
clue
first
residu
might
play
import
role
substrat
bind
order
clarifi
point
design
new
strategi
produc
wt
sarscov
pro
creat
gst
fusion
product
tag
remov
via
tabl
enzym
inhibit
data
inhibitor
four
type
sarscov
pro
wtgph
wt
autocleavag
mechan
enzym
three
reason
autoprocess
produc
addit
residu
n
terminu
sarscov
pro
report
highli
effici
express
gst
fusion
system
method
could
use
character
autocleavag
effici
sarscov
vitro
point
affin
gst
tag
mimic
transmembran
domain
upstream
sarscov
pro
polyprotein
repres
autocleavag
model
pro
vitro
sdspage
analysi
show
gst
tag
remov
entir
n
terminu
autoprocess
express
sarscov
pro
e
coli
exhibit
high
effici
autocleavag
vitro
previou
studi
hypothes
autocleavag
pro
may
occur
proxim
membran
data
suggest
complet
autocleavag
might
achiev
cytoplasm
although
precis
whereabout
assembl
replicas
complex
compon
remain
identifi
accord
separ
report
hsu
lin
use
autocleavag
remov
tag
thioredoxin
support
hypothesi
rhinovirus
coronavirus
belong
picornavirida
coronavirida
respect
previou
report
shown
cov
pro
could
effici
process
substrat
picornaviru
proteas
vice
versa
studi
interest
observ
substitut
site
result
convers
sarscov
main
proteas
substrat
rhinoviru
proteas
studi
demonstr
first
residu
n
terminu
sarscov
pro
import
activ
inhibitor
bind
critic
interact
involv
stabil
substratebind
pocket
two
hydrogen
bond
form
free
amino
group
first
residu
one
protom
two
residu
compris
subsit
partner
protom
within
dimer
structur
stabil
effect
free
amino
group
obviou
publish
gplgswt
structur
subsit
protom
b
partial
collaps
without
stabil
first
residu
protom
suggest
pocket
would
less
stabl
due
microenvironment
chang
crystal
step
structur
determin
procedur
larg
quantiti
wt
sarscov
pro
crystal
could
produc
one
night
could
easili
diffract
high
resolut
condit
describ
previous
contrast
usual
took
five
ten
day
produc
limit
amount
gplgswt
sarscov
pro
gswt
sarscov
pro
crystal
suitabl
diffract
albeit
compar
lower
resolut
consequ
wt
sarscov
pro
report
suitabl
activ
assay
inhibitor
screen
crystal
acceler
develop
anticoronaviru
inhibitor
structureassist
approach
drug
design
region
vector
clone
vector
two
primer
forward
revers
nucleotid
encod
specif
amino
acid
tsavlqsgfrk
recogn
sarscov
pro
introduc
revers
primer
recombin
plasmid
doubledigest
bstbi
bamhi
segment
interest
recombin
vector
also
doubledigest
bstbi
bamhi
construct
new
protein
express
vector
pgstm
clone
express
purif
calbindin
pgstm
protein
express
system
gene
encod
calbindin
amplifi
polymeras
chain
reaction
pcr
primer
pcr
product
ligat
vector
bacteriophag
dna
ligas
digest
bamhi
xhoi
gene
interest
insert
bamhi
xhoi
site
pgstm
vector
result
recombin
plasmid
transform
e
coli
strain
cell
cultur
lb
medium
contain
mg
ml
ampicillin
absorb
nm
reach
iptg
ad
mm
cell
cultur
incub
h
harvest
centrifug
beckman
pellet
resuspend
pb
mm
nacl
mm
kcl
mm
na
hpo
mm
kh
po
ph
sonic
ice
lysat
centrifug
beckman
minut
precipit
discard
supernat
load
onto
ml
gstglutathion
affin
column
pharmacia
equilibr
pb
wash
column
volum
pb
mg
sarscov
pro
gswt
ad
column
h
remov
gst
tag
protein
interest
collect
analyz
sdspage
express
purif
sarscov
pro
differ
number
addit
residu
n
terminu
describ
sarscov
pro
five
addit
residu
gplg
n
terminu
express
purif
gplgswt
sarscov
pro
report
briefli
code
sequenc
sarscov
pro
insert
bamhi
xhoi
site
plasmid
dna
ge
healthcar
result
plasmid
use
transform
e
coli
cell
gst
fusion
protein
gstsarscov
pro
purifi
gstglutathion
affin
chromatographi
cleav
gst
rhinoviru
proteas
recombin
sarscov
pro
purifi
anionexchang
chromatographi
sarscov
pro
two
addit
residu
gs
n
terminu
express
purif
gswt
sarscov
pro
report
briefli
code
sequenc
insert
bamhi
xhoi
site
vector
ge
healthcar
follow
procedur
similar
use
express
purif
sarscov
pro
plasmid
except
gst
fusion
protein
cleav
thrombin
wt
sarscov
pro
without
addit
residu
termini
code
sequenc
sarscov
pro
amplifi
polymeras
chain
reaction
pcr
use
pcr
primer
nucleotid
code
four
amino
acid
avlq
correspond
autocleavag
site
n
terminu
sarscov
pro
nomenclatur
substrat
amino
acid
residu
pn
pn
denot
hydrolyz
bond
sn
sn
denot
correspond
enzym
bind
site
ad
first
residu
nucleotid
code
eight
amino
acid
gph
ad
c
terminu
revers
primer
pcr
product
insert
bamhi
xhoi
site
plasmid
ge
healthcar
result
plasmid
use
transform
e
coli
cell
sequenc
insert
verifi
dideoxynucleotid
sequenc
posit
clone
harbor
recombin
plasmid
grown
shake
lb
medium
contain
mg
ml
ampicillin
gst
fusion
protein
express
introduc
iptg
mm
incub
continu
h
cell
harvest
centrifug
beckman
resuspend
lysi
buffer
mm
trishcl
ph
mm
nacl
sonic
ice
lysat
centrifug
beckman
min
supernat
collect
tag
fuse
protein
purifi
ninta
affin
chromatographi
concentr
presciss
cleavag
buffer
mm
trishcl
ph
mm
nacl
mm
edta
mm
dithiothreitol
mg
ml
human
rhinoviru
proteas
ad
ml
mg
ml
wtgph
solut
cleav
ctermin
tag
produc
sarscov
pro
authent
c
terminu
wt
sarscov
pro
purifi
use
anionexchang
chromatographi
protein
sampl
step
prepar
sdspage
analysi
wtgph
wt
analyz
malditof
ms
purifi
concentr
wt
sarscov
pro
mg
ml
store
mm
trishcl
mm
edta
enzym
activ
assay
crystal
enzym
activ
assay
gswt
sarscov
pro
describ
activ
assay
gplgswt
wtgph
wt
sarscov
pro
follow
similar
protocol
briefli
substrat
n
ctermin
authent
sarscov
pro
fluorogen
compound
mcaavlqsgfrli
dnp
greater
puriti
gl
biochem
shanghai
ltd
shanghai
china
excit
emiss
wavelength
fluorogen
substrat
nm
nm
respect
buffer
consist
mm
trishcl
ph
mm
edta
use
enzym
activ
assay
temperatur
reaction
initi
ad
proteas
final
concentr
wt
wtgph
gplgswt
solut
contain
differ
final
concentr
substrat
wt
wtgph
gplgswt
kinet
constant
k
k
cat
obtain
doublereciproc
plot
supplementari
data
figur
strict
r
merg
intens
individu
reflect
averag
intens
reflect
b
r
work
f
p
f
c
f
p
f
c
calcul
f
p
observ
structur
factor
amplitud
c
ramachandran
plot
gener
program
procheck
kinet
paramet
determin
inhibit
assay
crystal
data
collect
structur
determin
crystal
wt
sarscov
pro
carri
describ
prepar
cocryst
sarscov
pro
complex
inhibitor
report
set
wt
sarscov
pro
data
collect
singl
crystal
beamlin
advanc
photon
sourc
ap
argonn
nation
lab
wavelength
data
sarscov
pro
complex
collect
k
inhous
rigaku
rotatinganod
xray
gener
kv
rigaku
raxi
iv
imagepl
detector
data
process
integr
scale
merg
use
method
use
structur
determin
describ
briefli
structur
determin
molecular
replac
nativ
structur
sarscov
pro
ph
pdb
id
data
collect
structur
refin
statist
summar
tabl
coordin
structur
factor
wt
sarscov
pro
deposit
protein
data
bank
access
number
coordin
structur
factor
wt
sarscov
pro
complex
inhibitor
deposit
protein
data
bank
access
number
